One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
The Ensign Group logo
The Ensign Group ENSG
$ 173.35 -1.51%
report update icon

Quarterly report 2026-Q2
added 07-27-2026

The Ensign Group Income Statement 2025-2008 | ENSG

Brief overview of profit and loss at The Ensign Group

The figures are compared over a five-year interval. The revenue attributed to The Ensign Group moved from $2.4 billion to $5.1 billion between the two endpoints. Overall revenue changed by +110.5%, equal to an annualized rate of about 16.1%. The pace indicates confident and sustained business growth.

Gross profit was 537 million dollars at the start and 1 billion dollars at the end of the period (+93.3%). Revenue and direct costs changed at similar rates. At the margin level, the figure shifted from 22.4% to 20.5%. There was no meaningful shift in gross profitability.

The operating result measured by EBITDA moved from $278 million to $530 million, or +90.7%. Changes in revenue did not translate into comparable EBITDA performance. The EBITDA share of revenue changed from 11.6% to 10.5%. The EBITDA margin stayed near its previous level.

Over the period, net income shifted from $170 million to $344 million (+101.8%). The latest figure was the best within the selected horizon.

The five-year change in capitalization reached +137.4%: from 4.2 billion dollars to 9.9 billion dollars. Higher capitalization indicates improving investor confidence.

Conclusion

The financial profile remains mixed, with strengths and risks moving in different directions. The constructive conclusion rests on improving net profitability and sales growth. The overall view is constrained by a declining EBITDA margin and a lower gross margin. The key question is whether sales can be converted into sustainable profit.

Annual Income Statement The Ensign Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Market Cap

9.91 B 8.42 B 6.44 B 5.12 B 4.11 B 4.17 B 2.48 B 2.07 B 1.09 B 956 M 1.06 B 867 M 473 M 311 M 279 M 92.5 M 74.1 M -

Shares

57.3 M 56.7 M 55.7 M 54.9 M 54.5 M 53.4 M 53.5 M 52 M 50.9 M 50.6 M 50.3 M 44.7 M 43.8 M 42.9 M 41.9 M 20.7 M 20.6 M -

Historical Prices

173 149 116 93.2 75.4 78.1 44.9 40.3 21.2 18.6 20.3 18.7 10.2 6.9 6.34 4.46 3.6 2.77

Net Income

344 M 298 M 209 M 225 M 195 M 170 M 111 M 92.4 M 40.5 M 50 M 55.4 M 36 M 24 M 40.6 M 47.7 M 40.5 M 32.5 M -

Revenue

5.06 B 4.26 B 3.73 B 3.03 B 2.63 B 2.4 B 2.04 B 2.04 B 1.85 B 1.65 B 1.34 B 1.03 B 905 M 825 M 758 M - - -

Cost of Revenue

4.02 B 3.38 B 2.94 B 2.35 B 2.02 B 1.87 B 1.62 B 1.42 B 1.31 B 1.34 B - - - - - - - -

Gross Profit

- - - - - - 291 M 274 M 220 M 188 M 185 M 156 M 165 M 151 M 144 M - - -

Operating Income

425 M 358 M 255 M 297 M 260 M 223 M 129 M 84.9 M 43.2 M 91.8 M 93.1 M 72.9 M 57.9 M 78.3 M 90.7 M 75.7 M 58.9 M -

Interest Expense

13.8 M 7.33 M 8.09 M 8.93 M 6.85 M 9.36 M 15.7 M 15.2 M 13.6 M 7.14 M 2.83 M 13 M 12.8 M 12.2 M 13.8 M 9.12 M 5.69 M -

EBITDA

530 M 442 M 328 M 359 M 316 M 278 M 180 M 174 M 139 M 119 M 121 M 99.4 M 125 M 120 M 114 M 92.3 M 72.2 M -

Operating Expenses

- - - - - - 162 M 148 M 125 M 108 M 92.3 M 83.3 M 74 M 60.3 M 53.1 M - - -

General and Administrative Expenses

270 M 225 M 263 M 159 M 152 M 130 M 111 M 100 M 80.6 M 69.2 M 64.2 M 56.9 M 40.1 M 31.8 M 29.8 M 26.1 M 20.8 M -

All numbers in USD currency

Quarterly Income Statement The Ensign Group

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

58 M 57.8 M 57.4 M 57.2 M 57.1 M 57.4 M 56.8 M 56.5 M 56.3 M 56.6 M 55.8 M 55.6 M 55.3 M 55.7 M 54.9 M 54.9 M 54.7 M 55.2 M 54.6 M 54.5 M 54.2 M 54.6 M 53.3 M 53.1 M 53.5 M 53.5 M 53.9 M 53.4 M 53.1 M 52.6 M 52.1 M 51.9 M 51.6 M 51.4 M 50.9 M 50.7 M 50.8 M 50.8 M 50.5 M 50.3 M 50.7 M 51.4 M 51.1 M 50.9 M 47.8 M 22.6 M 22.4 M 22.3 M 22.2 M 22.1 M 21.9 M 21.9 M 22.1 M 21.7 M 21.7 M 21.7 M 21.3 M 21.2 M 21 M 20.9 M 20.9 M

Net Income

99.7 M 99.7 M 83.8 M 84.4 M 80.3 M - 78.4 M 71 M 68.8 M - 63.9 M 64 M 59.9 M - 56.2 M 57.7 M 50.3 M - 47.3 M 49.4 M 49.2 M - 43.1 M 40.2 M 40.8 M - 27.2 M 28.6 M 27.4 M - 20.9 M 22 M 23.1 M - 14.2 M 12.2 M 2.84 M - 11.2 M 11.3 M 9.17 M - 13.5 M 13.2 M 15.2 M - 8.91 M 2.01 M 13.5 M - 10.5 M 12.4 M -12.1 M - 13.3 M 12.5 M 12.9 M - 11.6 M 13 M 12.7 M

Revenue

1.44 B 1.39 B 1.3 B 1.23 B 1.17 B - 1.08 B 1.04 B 1.01 B - 941 M 921 M 887 M - 770 M 732 M 713 M - 669 M 639 M 627 M - 599 M 585 M 590 M - 512 M 493 M 471 M - 514 M 496 M 492 M - 472 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

1.13 B 1.1 B 1.04 B 972 M 928 M - 860 M 820 M 799 M - 741 M 723 M 696 M - 602 M 564 M 556 M - 514 M 489 M 482 M - 465 M 452 M 455 M - 411 M 395 M 372 M - 414 M 396 M 390 M - 382 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

123 M 125 M 96.2 M 104 M 101 M - 89.3 M 86 M 82.2 M - 79.8 M 77.9 M 74.9 M - 74.3 M 78.2 M 69.1 M - 66.3 M 64.9 M 63.7 M - 55.1 M 55.4 M 56.8 M - 30.8 M 28.7 M 29.9 M - 29.3 M 31.8 M 33 M - 25.6 M 22 M 7.55 M - 20 M 19.8 M 16.3 M - 21.6 M 22 M 25.2 M - 15.3 M 13.6 M 24.3 M - 20.3 M 23.3 M -10.8 M - 23.5 M 23.3 M 23.5 M - 23.9 M 24.1 M 23.7 M

Interest Expense

8.47 M -885 K 6.18 M 5.24 M 361 K - 3.75 M 1.05 M 2.88 M - -982 K 3.18 M 2.04 M - 2.11 M 2.69 M 2.07 M - 1.71 M 1.63 M 1.64 M - 1.74 M 2.29 M 3.66 M - 3.9 M 3.94 M 3.67 M - 3.99 M 3.87 M 3.61 M - 3.52 M 3.05 M 3.44 M - 2.14 M 1.45 M 1.37 M - 802 K 567 K 667 K - 407 K 8.72 M 3.36 M - 3.18 M 3.14 M 3.12 M - 3.09 M 3.11 M 2.92 M - 5.32 M 2.74 M 2.73 M

EBITDA

154 M 154 M 123 M 130 M 126 M - 111 M 106 M 102 M - 98.2 M 95.5 M 92 M - 90.2 M 93.1 M 83.8 M - 80.2 M 78.6 M 77.3 M - 68.8 M 69 M 70.5 M - 44.2 M 41.1 M 41.9 M - 41.2 M 43.4 M 44.6 M - 37 M 32.8 M 18.1 M - 31 M 29.6 M 24.6 M - 28.9 M 28.4 M 31.7 M - 20 M 21.4 M 33.2 M 1.33 M 29.1 M 32 M -3.02 M - 30.7 M 30.3 M 30.4 M - 30.1 M 29.7 M 28.8 M

General and Administrative Expenses

85.9 M 74.2 M 67.4 M 69.1 M 62.6 M - 56.2 M 56.2 M 57.2 M - 51.1 M 53.4 M 51.9 M - 39.2 M 38.5 M 38.3 M - 38.6 M 36.9 M 34.3 M - 32.8 M 31.4 M 32.2 M - 25.5 M 25.8 M 27.3 M - 24.6 M 22.4 M 25.1 M - 19.3 M 17.3 M 21.3 M - 17.3 M 19.7 M 17.4 M - 17.2 M 15.3 M 14.4 M - 13 M 18.3 M 13.2 M - 10.6 M 8.87 M 8.85 M - 8.1 M 8.14 M 7.7 M - 7.2 M 7.59 M 7.4 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company The Ensign Group (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
Мать и Дитя Мать и Дитя
MDMG
- - - russiaRussia
ЮМГ ЮМГ
GEMC
- - - russiaRussia
IMAC Holdings IMAC Holdings
IMAC
- -1.77 % $ 25.4 M usaUSA
ModivCare ModivCare
MODV
- -25.23 % $ 6.12 M usaUSA
National HealthCare Corporation National HealthCare Corporation
NHC
$ 235.6 -4.79 % $ 3.65 B usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
$ 39.25 1.16 % $ 1.59 B usaUSA
Chemed Corporation Chemed Corporation
CHE
$ 511.37 -1.02 % $ 7.36 B usaUSA
American Shared Hospital Services American Shared Hospital Services
AMS
$ 1.25 -2.34 % $ 8.27 M usaUSA
AMN Healthcare Services AMN Healthcare Services
AMN
$ 43.01 3.49 % $ 1.66 B usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
$ 31.43 0.14 % $ 2.85 B usaUSA
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
$ 3.68 -14.02 % $ 482 M chinaChina
Encompass Health Corporation Encompass Health Corporation
EHC
$ 120.47 -0.99 % $ 12.1 B usaUSA
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
$ 22.55 -0.66 % $ 11.2 B usaUSA
Oak Street Health Oak Street Health
OSH
- 0.03 % $ 9.53 B usaUSA
Ontrak Ontrak
OTRK
- -11.98 % $ 1.53 M usaUSA
Amedisys Amedisys
AMED
- 0.01 % $ 3.3 B usaUSA
Tivity Health Tivity Health
TVTY
- 0.09 % $ 1.6 B usaUSA
SunLink Health Systems SunLink Health Systems
SSY
- 17.98 % $ 7.81 M usaUSA
LHC Group LHC Group
LHCG
- - $ 5.27 B usaUSA
Hanger Hanger
HNGR
- - $ 732 M usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
- -13.87 % $ 1.52 M usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
$ 21.56 0.7 % $ 6.28 B germanyGermany
Option Care Health Option Care Health
OPCH
$ 31.29 -0.22 % $ 5.07 B usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
$ 11.84 -0.5 % $ 1.11 B britainBritain
Community Health Systems Community Health Systems
CYH
$ 2.82 -1.05 % $ 377 M usaUSA
Surgery Partners Surgery Partners
SGRY
$ 15.4 -0.58 % $ 1.96 B usaUSA
Sanara MedTech Sanara MedTech
SMTI
$ 32.77 -1.12 % $ 283 M usaUSA
HCA Healthcare HCA Healthcare
HCA
$ 459.4 -1.36 % $ 109 B usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
$ 269.13 -1.17 % $ 24.3 B usaUSA
Universal Health Services Universal Health Services
UHS
$ 182.87 -1.48 % $ 11.6 B usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
$ 117.95 -0.07 % $ 2.13 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
$ 21.71 0.98 % $ 1.57 B usaUSA
DaVita DaVita
DVA
$ 176.81 0.83 % $ 13.1 B usaUSA
MEDNAX MEDNAX
MD
$ 28.1 0.07 % $ 2.36 B usaUSA
The Pennant Group The Pennant Group
PNTG
$ 41.04 -1.06 % $ 1.42 B usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
$ 86.28 -0.85 % $ 1.31 B usaUSA
Brookdale Senior Living Brookdale Senior Living
BKD
$ 10.08 0.1 % $ 2.37 B usaUSA
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
- -2.09 % $ 216 M usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
- 3.54 % $ 1.5 B usaUSA
The Joint Corp. The Joint Corp.
JYNT
$ 7.17 -0.28 % $ 109 M usaUSA
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
- 10.96 % $ 46.2 M chinaChina
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
- -0.32 % $ 98.4 M usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
- - $ 68.1 M usaUSA
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
- 26.45 % $ 70.6 M usaUSA
Apollo Medical Holdings Apollo Medical Holdings
AMEH
- -2.11 % $ 1.84 B usaUSA
Regional Health Properties Regional Health Properties
RHE
- - $ 5.2 M usaUSA
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
- - $ 2.02 B usaUSA